221 related articles for article (PubMed ID: 25805938)
1. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ
World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study.
Fumery M; Dupont C; Ley D; Savoye G; Bertrand V; Guillon N; Wils P; Gower-Rousseau C; Sarter H; Turck D; Leroyer A
Dig Liver Dis; 2024 Jan; 56(1):21-28. PubMed ID: 37137808
[TBL] [Abstract][Full Text] [Related]
3. Combination of Biological Agents in Moderate to Severe Pediatric Inflammatory Bowel Disease: A Case Series and Review of the Literature.
Olbjørn C; Rove JB; Jahnsen J
Paediatr Drugs; 2020 Aug; 22(4):409-416. PubMed ID: 32378002
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Immunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
Osterman MT; Haynes K; Delzell E; Zhang J; Bewtra M; Brensinger CM; Chen L; Xie F; Curtis JR; Lewis JD
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1293-1301.e5; quiz e70, e72. PubMed ID: 25724699
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
Pascual-Oliver A; Casas-Deza D; Cuarán C; García-López S; Corsino-Roche P; Sierra-Moros E; Olier-Martínez P; González-Tarancón R; Vicente-Lidón R
Inflamm Bowel Dis; 2024 Jun; 30(6):922-929. PubMed ID: 37462462
[TBL] [Abstract][Full Text] [Related]
6. Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users.
Al-Fadel N; Almutairi A; Aldhirgham T; Abuesba L; Alrwisan A; Alharbi F
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5682. PubMed ID: 37615200
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis on the association of tuberculosis in Crohn's disease patients treated with tumor necrosis factor-α inhibitors (Anti-TNFα).
Cao BL; Qasem A; Sharp RC; Abdelli LS; Naser SA
World J Gastroenterol; 2018 Jul; 24(25):2764-2775. PubMed ID: 29991880
[TBL] [Abstract][Full Text] [Related]
8. RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS.
Cury DB; Cury LCB; Micheletti AC; Oliveira RA; Gonçalves JJS
Arq Gastroenterol; 2024; 61():e23148. PubMed ID: 38511796
[TBL] [Abstract][Full Text] [Related]
9. Infections in inflammatory bowel disease patients on immunomodulator and biologic therapy are not associated with high serum drug levels.
Gazelakis K; Chu I; Martin C; Sparrow MP
Intern Med J; 2024 Jan; 54(1):139-148. PubMed ID: 37151186
[TBL] [Abstract][Full Text] [Related]
10. Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases.
Singh S; Heien HC; Sangaralingham L; Shah ND; Sandborn WJ
Clin Transl Gastroenterol; 2021 Jul; 12(7):e00380. PubMed ID: 34228004
[TBL] [Abstract][Full Text] [Related]
11. Frequency of latent tuberculosis in patients receiving Anti-TNF-Alpha therapy.
Coşkunol İ; Turan O; Baysak A; Solmaz D; Can G
Afr Health Sci; 2023 Jun; 23(2):128-132. PubMed ID: 38223592
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis.
Tassone D; Basnayake C; Wright E; Lust M; Kamm MA; Niewiadomski O; Schulberg J; Flanagan E; Samyue T; Fry S; Malcolm R; Stanley A; Thompson AJ; Connell WR; Ding NS
Intern Med J; 2024 Mar; 54(3):446-454. PubMed ID: 37255273
[TBL] [Abstract][Full Text] [Related]
13. Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-alpha treatment in relation to British Thoracic Society guidelines.
John H; Buckley C; Koh L; Obrenovic K; Erb N; Rowe IF;
Clin Med (Lond); 2009 Jun; 9(3):225-30. PubMed ID: 19634383
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis infection in patients with inflammatory bowel diseases. Clinacal cases].
Timanovskaia MU; Shaykhtdinova YR; Zhulina EU; Kulakov DS; Kagramanova AV; Knyzev OV; Parfenov AI
Ter Arkh; 2023 Dec; 95(11):979-984. PubMed ID: 38158956
[TBL] [Abstract][Full Text] [Related]
15. Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015-2020).
Lee J; Seo H; Kim D; Hwang J; Kwon JW
J Microbiol Immunol Infect; 2024 Jun; 57(3):437-445. PubMed ID: 38627123
[TBL] [Abstract][Full Text] [Related]
16. Concomitant disseminated histoplasmosis and disseminated tuberculosis after tumor necrosis factor inhibitor treatment: a case report.
Muñoz-Oca JE; Villarreal Morales ML; Nieves-Rodriguez A; Martínez-Bonilla L
BMC Infect Dis; 2017 Jan; 17(1):70. PubMed ID: 28086756
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response.
Lichtenstein GR
Therap Adv Gastroenterol; 2013 Jul; 6(4):269-93. PubMed ID: 23814608
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
Collen LV; Mitsialis V; Kim DY; Bresnahan M; Yang J; Tuthill M; Combs A; Barends J; Field M; Liu E; Bearup R; Okoroafor I; Klein C; Muise AM; Bousvaros A; Ouahed J; Snapper SB
Inflamm Bowel Dis; 2023 Oct; ():. PubMed ID: 37847820
[TBL] [Abstract][Full Text] [Related]
19. New-onset Blepharitis and Anti-TNF-Alpha Therapy in Patients with Crohn's Disease: A Case Series and Literature Review.
Weintraub Y; Lev-Tzion R; Ollech J; Olshaker H; Rosen I; Cohen S; Varssano D; Shouval DS; Matar M
Isr Med Assoc J; 2023 Dec; 25(12):836-840. PubMed ID: 38142326
[No Abstract] [Full Text] [Related]
20. Miliary Tuberculosis in a Crohn's Disease Patient: The Risk beyond the Screening.
Carvalho LP; Túlio MA; Rodrigues JP; Bana E Costa T; Chagas C
GE Port J Gastroenterol; 2018 Dec; 26(1):64-69. PubMed ID: 30675506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
